Skip to main navigation Skip to search Skip to main content

Haploid Human Embryonic Stem Cells: Half the Genome, Double the Value

  • Atilgan Yilmaz
  • , Mordecai Peretz
  • , Ido Sagi*
  • , Nissim Benvenisty
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate

32 Scopus citations

Abstract

Recent advances in the generation of haploid embryonic stem cells (ESCs), capable of self-renewal and differentiation, have laid the groundwork for numerous biomedical applications in developmental biology and reproductive medicine. When combined with the power of genetic screening, haploid human ESCs could advance cancer research, regenerative medicine, and disease modeling.

Original languageEnglish
Pages (from-to)569-572
Number of pages4
JournalCell Stem Cell
Volume19
Issue number5
DOIs
StatePublished - 3 Nov 2016

Bibliographical note

Publisher Copyright:
© 2016 Elsevier Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Haploid Human Embryonic Stem Cells: Half the Genome, Double the Value'. Together they form a unique fingerprint.

Cite this